Critical illness polyneuropathy | |
---|---|
Specialty | Neurology |
Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are overlapping syndromes of diffuse, symmetric, flaccid muscle weakness occurring in critically ill patients and involving all extremities and the diaphragm with relative sparing of the cranial nerves. CIP and CIM have similar symptoms and presentations and are often distinguished largely on the basis of specialized electrophysiologic testing or muscle and nerve biopsy.[1][2] The causes of CIP and CIM are unknown, though they are thought to be a possible neurological manifestation of systemic inflammatory response syndrome.[3] Corticosteroids and neuromuscular blocking agents, which are widely used in intensive care, may contribute to the development of CIP and CIM,[4] as may elevations in blood sugar, which frequently occur in critically ill patients.[5]
CIP was first described by Charles F. Bolton in a series of five patients.[6]
Combined CIP and CIM was first described by Nicola Latronico in a series of 24 patients.[7]
EJN
was invoked but never defined (see the help page).